GNI Group Ltd
TSE:2160

Watchlist Manager
GNI Group Ltd Logo
GNI Group Ltd
TSE:2160
Watchlist
Price: 3 380 JPY 5.13% Market Closed
Market Cap: 169.4B JPY
Have any thoughts about
GNI Group Ltd?
Write Note

GNI Group Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GNI Group Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
GNI Group Ltd
TSE:2160
Effect of Foreign Exchange Rates
-ÂĄ869.7m
CAGR 3-Years
N/A
CAGR 5-Years
-38%
CAGR 10-Years
-42%
PeptiDream Inc
TSE:4587
Effect of Foreign Exchange Rates
-ÂĄ160.3m
CAGR 3-Years
N/A
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Effect of Foreign Exchange Rates
ÂĄ1.3B
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
27%
Pharma Foods International Co Ltd
TSE:2929
Effect of Foreign Exchange Rates
ÂĄ5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-8%
S
StemRIM Inc
TSE:4599
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Effect of Foreign Exchange Rates
ÂĄ1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

GNI Group Ltd
Glance View

Market Cap
169.2B JPY
Industry
Biotechnology

GNI Group Ltd. engages in the development, research, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 629 full-time employees. The company went IPO on 2007-08-31. The firm is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. The company is engaged in research and development of therapeutic agents, including F647 for radiation pneumonia (RP) and idiopathic pulmonary fibrosis (IPF), F351 for liver fibrosis (cirrhosis) and F573 for acute hepatic insufficiency and acute chronic liver failure (ACLF).

Intrinsic Value
4 956.28 JPY
Undervaluation 32%
Intrinsic Value
Price

See Also

What is GNI Group Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-869.7m JPY

Based on the financial report for Sep 30, 2024, GNI Group Ltd's Effect of Foreign Exchange Rates amounts to -869.7m JPY.

What is GNI Group Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 10Y
-42%

Back to Top